Inspire Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results

RALEIGH, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today financial results for the first quarter ended March 31, 2011, reporting a net loss of $17.6 million or ($0.21) per common share, as compared to a net loss of $14.8 million, or ($0.18) per common share, for the same period in 2010. The Company’s first quarter 2011 results included a $12.2 million restructuring charge associated with the discontinuation of the Company’s pulmonary therapeutic operations and other related infrastructure reductions.